US Stock MarketDetailed Quotes

PROK ProKidney

Watchlist
  • 2.710
  • 0.0000.00%
Close Apr 25 16:00 ET
  • 2.708
  • -0.003-0.09%
Post 17:16 ET
166.99MMarket Cap-4754P/E (TTM)

About ProKidney Company

ProKidney Corp（formerly Social Capital Suvretta Holdings Corp. III） is an advanced biotechnology company founded by innovators. The company was founded on 2015, is a pioneer in the innovative treatment of chronic kidney disease (CKD) through cell therapy.

Company Profile

SymbolPROK
Company NameProKidney
Listing DateJun 30, 2021
Founded2015
CEODr. Bruce Culleton, M.D.
MarketNASDAQ
Employees163
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address2000 Frontis Plaza Boulevard,Suite 250
CityWinston-Salem
ProvinceNorth Carolina
CountryUnited States of America
Zip Code27103
Phone1-336-999-7028
Websitehttps://www.prokidney.com/

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Bruce Culleton, M.D.
  • Chief Executive Officer and Director
  • --
  • Todd C. Girolamo
  • Chief Legal Officer
  • 8.24M
  • James Coulston, C.P.A.
  • Chief Financial Officer and Principal Accounting Officer
  • --
  • Dr. Darin J. Weber, PhD
  • Chief Regulatory Officer and Senior Vice President, Regulatory Affairs, Quality, Biometrics & Market Access
  • --
  • Dr. Joseph Stavas, M.D.
  • Senior Vice President and Global Head of Clinical Development and Interventional Procedures
  • --
  • Ashley H. Johns
  • Senior Vice President and Head of Global Clinical Operations
  • --
  • Dr. Ulrich Ernst, PhD
  • Executive Vice President, Technical Operations
  • --
  • Pablo Legorreta
  • Chairman of the Board
  • 35.00K
  • Jose Ignacio Jimenez Santos
  • Independent Director
  • 35.00K
  • Dr. John M. Maraganore,PhD
  • Independent Director
  • 4.35M
  • Dr. Alan M. Lotvin, M.D.
  • Independent Director
  • 9.70M
  • William F. Doyle
  • Independent Director
  • 9.70M
  • Dr. Brian J.G. Pereira,M.D.
  • Independent Director
  • 9.70M
  • Jennifer A. Fox
  • Independent Director
  • 950.93K
  • Dr. Uma Sinha, PhD
  • Independent Director
  • 25.50K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg